# A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-2-trial-of-guselkumab-versus-adalimumab-for-plaque-psoriasis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kenneth B. Gordon,Kristina Callis Duffin,Robert Bissonnette,Jörg C. Prinz,Yasmine Wasfi,Shu Li,Yaung‐Kaung Shen,Philippe Szapary,B. Randazzo,Kristian Reich |
| Citations | 300 |
| DOI | 10.1056/nejmoa1501646 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1501646?articleTools=true |
| OpenAlex ID | https://openalex.org/W823422456 |
| PMID | 26154787 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Philippe Szapary](https://scholariq.org/researchers/philippe-szapary/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Hidradenitis Suppurativa and Treatments](https://scholariq.org/topics/hidradenitis-suppurativa-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.